Prospective randomized controlled study of Daikenchuto for postoperative dysmotility after total gastrectomy:

Prospective randomized controlled study of Daikenchuto for postoperative dysmotility after total gastrectomy: - Daikenchuto for postoperative dysmotility

Status

Unknown

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000002090

Enrollment

100

Registered

2009-06-18

Start date

2007-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer

Interventions

Take Daikenchuto for three months Not take Daikenchuto for three months

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Patients expected to be undergone total gastrectomy with Curabirity A or B for gastric cancer 2)Patients should have total gastrectomy with Roux-en Y reconstraction. 3)Age: Between 20 and 80 years old regardless of gender 4)Written informed consent

Exclusion criteria

Exclusion criteria: 1)Patients under emergent operation Patients with double cancer 2)Patients with severe or uncontrollable diseases related with heart, lung, liver, and kidney 3)Patients with previous open laparotomy (except the Appendectomy) 4)Patients with pregnancy or under lactation, patients expected to be under pregnancy, and patients wish to be pregnancy 5)Patients judged inappropriate by his or her doctor

Design outcomes

Primary

Measure	Time frame
Improvement of postoperative symptoms and signs due to gastrointestinal dysmotility including postoperative ileus, abodominal pain, distansion	—

Secondary

Measure	Time frame
Safety of Daikenchuto	—

Countries

Japan

Contacts

Public ContactToshirou Nishida

Osaka University Graduate School of Medicine Department of Gastrointestinal Surgery

06-6879-3251

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026